{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:26:32Z","timestamp":1787945192639,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijcard.2025.134147","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T15:20:58Z","timestamp":1767280858000},"page":"134147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Relationship between symptom assessment and cardiopulmonary exercise testing in patients with obstructive hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"447","author":[{"given":"Louise","family":"Bjerregaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten S.K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Dybro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten Bloch","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen Hvitfeldt","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan J.","family":"Rowin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ijcard.2025.134147_bb0005","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the Management of Hypertrophic Cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on clinical practice guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2025.134147_bb0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jacc.2009.01.079","article-title":"Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study","volume":"54","author":"Sorajja","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2025.134147_bb0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ahj.2015.02.006","article-title":"Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography","volume":"169","author":"Masri","year":"2015","journal-title":"Am. Heart J."},{"issue":"37","key":"10.1016\/j.ijcard.2025.134147_bb0020","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2025.134147_bb0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"10253","key":"10.1016\/j.ijcard.2025.134147_bb0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.ijcard.2025.134147_bb0035","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2025.134147_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2022.04.048","article-title":"Myosin inhibition in patients with obstructive hypertrophic cardiomyopathy referred for septal reduction therapy","volume":"80","author":"Desai","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2025.134147_bb0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40256-024-00667-z","article-title":"Novel cardiac myosin inhibitor therapy for hypertrophic cardiomyopathy in adults: a contemporary review","volume":"24","author":"Kalinski","year":"2024","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"6","key":"10.1016\/j.ijcard.2025.134147_bb0050","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.002248","article-title":"Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy","volume":"8","author":"Coats","year":"2015","journal-title":"Circ. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2025.134147_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jchf.2023.10.004","article-title":"Exercise capacity in patients with obstructive hypertrophic cardiomyopathy: SEQUOIA-HCM baseline characteristics and study design","volume":"12","author":"Coats","year":"2024","journal-title":"JACC Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcard.2025.134147_bb0060","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jchf.2014.11.011","article-title":"Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment","volume":"3","author":"Finocchiaro","year":"2015","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2025.134147_bb0065","first-page":"14","article-title":"Safety and efficacy of Mavacamten and Aficamten in patients with hypertrophic cardiomyopathy","author":"Davis","year":"2025","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"10.1016\/j.ijcard.2025.134147_bb0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jchf.2022.03.002","article-title":"Validation of the Kansas City cardiomyopathy questionnaire in symptomatic obstructive hypertrophic cardiomyopathy","volume":"10","author":"Nassif","year":"2022","journal-title":"JACC Heart Fail."},{"issue":"20","key":"10.1016\/j.ijcard.2025.134147_bb0075","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City cardiomyopathy questionnaire in clinical trials and clinical care: JACC state-of-the-art review","volume":"76","author":"Spertus","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.ijcard.2025.134147_bb0080","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.jacc.2021.07.065","article-title":"Randomized trial of metoprolol in patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Dybro","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Supplement_1","key":"10.1016\/j.ijcard.2025.134147_bb0085","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1513\/AnnalsATS.201612-997FR","article-title":"Cardiopulmonary exercise testing: basics of methodology and measurements","volume":"14","author":"Mezzani","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"8","key":"10.1016\/j.ijcard.2025.134147_bb0090","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jchf.2016.03.022","article-title":"Cardiopulmonary exercise testing in heart failure","volume":"4","author":"Malhotra","year":"2016","journal-title":"JACC Heart Fail."},{"issue":"18","key":"10.1016\/j.ijcard.2025.134147_bb0095","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/CIRCULATIONAHA.107.686576","article-title":"Development of a ventilatory classification system in patients with heart failure","volume":"115","author":"Arena","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2025.134147_bb0100","first-page":"467","article-title":"Cardiopulmonary exercise test: background, applicability and interpretation","volume":"107","author":"Herdy","year":"2016","journal-title":"Arq. Bras. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2025.134147_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3949\/ccjm.84a.15013","article-title":"Cardiopulmonary exercise testing: a contemporary and versatile clinical tool","volume":"84","author":"Leclerc","year":"2017","journal-title":"Cleve. Clin. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2025.134147_bb0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11739-012-0866-x","article-title":"Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study","volume":"9","author":"Magri","year":"2014","journal-title":"Intern. Emerg. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2025.134147_bb0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCHEARTFAILURE.108.834168","article-title":"Determining the preferred percent-predicted equation for peak oxygen consumption in patients with heart failure","volume":"2","author":"Arena","year":"2009","journal-title":"Circ. Heart Fail."},{"issue":"4","key":"10.1016\/j.ijcard.2025.134147_bb0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cardfail.2016.12.002","article-title":"Comparison between the Kansas City cardiomyopathy questionnaire and New York heart Association in assessing functional capacity and clinical outcomes","volume":"23","author":"Hawwa","year":"2017","journal-title":"J. Card. Fail."},{"issue":"11","key":"10.1016\/j.ijcard.2025.134147_bb0125","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jcmg.2017.07.016","article-title":"Role of exercise testing in hypertrophic cardiomyopathy","volume":"10","author":"Rowin","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"7","key":"10.1016\/j.ijcard.2025.134147_bb0130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ejhf.2923","article-title":"NYHA classification for decision-making in heart failure: time to reassess?","volume":"25","author":"Zimerman","year":"2023","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2025.134147_bb0135","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11136-012-0182-y","article-title":"Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy","volume":"22","author":"Huff","year":"2013","journal-title":"Qual. Life Res."},{"issue":"10","key":"10.1016\/j.ijcard.2025.134147_bb0140","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.amjcard.2012.01.363","article-title":"Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"109","author":"Sorajja","year":"2012","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2025.134147_bb0145","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.ahj.2009.06.006","article-title":"Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy","volume":"158","author":"Le","year":"2009","journal-title":"Am. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2025.134147_bb0150","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/01.CIR.92.10.2886","article-title":"Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics","volume":"92","author":"Lele","year":"1995","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325011908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325011908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:12:34Z","timestamp":1768338754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527325011908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"alternative-id":["S0167527325011908"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.134147","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between symptom assessment and cardiopulmonary exercise testing in patients with obstructive hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.134147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134147"}}